Long-Term Treatment with Sodium Phenylbutyrate in Ornithine Transcarbamylase-Deficient Patients
- 1 April 2001
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 72 (4) , 351-355
- https://doi.org/10.1006/mgme.2001.3156
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Human DnaJ Homologs dj2 and dj3, and bag-1 Are Positive Cochaperones of hsc70Journal of Biological Chemistry, 2000
- A successful pregnancy in a heterozygote for OTC deficiency treated with sodium phenylbutyrateNeurology, 2000
- Treatment of urea cycle disordersThe Journal of Pediatrics, 1999
- Blood Levels of Ammonia and Nitrogen Scavenging Amino Acids in Patients with Inherited HyperammonemiaMolecular Genetics and Metabolism, 1999
- Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophyNature Medicine, 1998
- Iatrogenic isolated isoleucine deficiency as the cause of an acrodermatitis enteropathica-like syndromeBritish Journal of Dermatology, 1998
- A Pilot Clinical Trial of Oral Sodium 4-Phenylbutyrate (Buphenyl) in Δ F508-Homozygous Cystic Fibrosis PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Long-Term Treatment of Girls with Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1996
- Ornithine Transcarbamylase Deficiency in Females: An Often Overlooked Cause of Treatable EncephalopathyJournal of Child Neurology, 1995
- Allopurinol challenge test in childrenJournal of Inherited Metabolic Disease, 1991